Sanofi-Aventis
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
174 Avenue De France, Paris, 75635, CEDE...Phone Number
+33 153774000Revenue
$19.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sanofi-Aventis
Item 4. Information on the Company Introduction We are a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. In 2006, our net sales amounted to €28,373 million. Based on 2006 sales, we are the fourth largest pharmaceutical group in the world and the largest pharmaceutical group in Europe (source: IMS/GERS consolidated sales year end 2006; all available channels). Sanofi-aventis is the parent of a consolidated group of com...Explore more
Popular SearchesSanofi-Aventis SASIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sanofi-Aventis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sanofi-Aventis is spiking on competitors!
Click to see if Sanofi-Aventis had a recent Job posting/layoffs
Product Launch: Get notified when Sanofi-Aventis launches new products
Earning: See what the market has to say on Sanofi-Aventis recently announced quarterly report
Sanofi-Aventis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sanofi-Aventis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Sanofi-Aventis
Funding: Get notified immidiatlly once Sanofi-Aventis has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Sanofi-Aventis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sanofi-Aventis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sanofi-Aventis.
Sanofi-Aventis News & Media
Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.
SAN DIEGO, Jan. 22, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Bioverativ Inc., and Juno Therapeutics, Inc., as detailed below: Bioverativ Inc.Shareholder rights law firm Johnson Fistel, LLP has launched an...Technical Perspectives on Drug Makers Stocks -- Aerie Pharma, Pfizer, Novartis, and Sanofi
NEW YORK, Jan. 4, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AERI, PFE, NVS, and SNY which can be accessed for free by signing up to www.wallstequities.com/registration. Pharmaceutical...Wired News – Alnylam Pharma Receives FDA Clearance for Fitsurian - Set to Resume its Phase-II and Phase-III Studies
LONDON, UK / ACCESSWIRE / December 18, 2017 / Active-Investors issued a free report on Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), which is readily accessible upon registration at www.active-investors.com/registration-sg/?symbol=ALNY as the Company's latest news hit the wire. Alnylam Pharma and Sanofi Genzyme (NYSE: SNY) - an American biotechnology Company, announced on December 15, 2017, that the US Food and Drug Administration (FDA) has cleared the hold on clinical studies with fitusrian, whCurisium Raises $3.5M to Scale Innovative Healthcare Contracting on Blockchain
MANHATTAN BEACH, Calif., Dec. 14, 2017 /PRNewswire/ -- Curisium, a healthcare technology and services company that enables innovative contracting at scale via its blockchain-based platform, announced today it has raised $3.5M in seed financing from Flare Capital Partners, New Enterprise...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sanofi-Aventis
Sign Up For FreeTo access detailed company insights
Item 4. Information on the Company Introduction We are a global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. In 2006, our net sales amounted to €28,373 million. Based on 2006 sales, we are the fourth largest pharmaceutical group in the world and the largest pharmaceutical group in Euro... Read More
